Evaluation of a New Molecular Entity as a Victim of Metabolic Drug-Drug Interactions—an Industry PerspectiveTonika Bohnert, Aarti Patel, Ian E. Templeton et al.|Drug Metabolism and Disposition|2016Cited by 110